This inventor holds 6 USPTO granted patents and 17 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Duke University, Triad National Security, LLC, The United States of America as Represented by the Department of Energy. Active years: 2021-2026.
Company Filing History:
5 out of 2,075 
3 out of 307 
1 out of 1,211 
Years Active: 2021-2026
Title: Kevin O. Saunders: Innovator in HIV Research
Introduction
Kevin O. Saunders is a prominent inventor based in Durham, NC, known for his significant contributions to HIV research. With a total of five patents to his name, he has made strides in developing immunogens aimed at inducing immune responses against HIV.
Latest Patents
Among his latest patents, one notable invention is titled "Compositions comprising HIV envelopes to induce CH235 lineage antibodies." This invention provides HIV-1 immunogens, including HIV-1 envelope selections from individual CH505, and outlines methods for swarm immunizations using combinations of HIV-1 envelopes. Another significant patent is "Compositions comprising modified HIV envelopes," which focuses on immunogens and methods for inducing immune responses. This includes techniques for germline B cell stimulation and maturation through the reverse engineering of HIV-1 envelopes.
Career Highlights
Kevin has worked with esteemed institutions such as Duke University and Triad National Security, LLC. His work in these organizations has allowed him to advance his research and contribute to the scientific community's understanding of HIV.
Collaborations
Throughout his career, Kevin has collaborated with notable colleagues, including Barton F. Haynes and Mattia Bonsignori. These partnerships have further enriched his research and innovation in the field.
Conclusion
Kevin O. Saunders stands out as a dedicated inventor whose work in HIV research has the potential to make a significant impact on public health. His innovative patents and collaborations reflect his commitment to advancing medical science.